. Step 22 of 40
Clinical Stem 2
A patient with pulmonary nodules 1 year after curative intent resection of primary lung adenocarcinoma

Question 6
Which of the following elements help ensure specimen adequacy for effective molecular analysis?
A. Document sample type, such as cytology or tissue biopsy, how it was obtained, and the location from where it was obtained.

B. Document the date and time of sample acquisition

C. Inform pathologists that a diagnosis of lung cancer or lung cancer recurrence is suspected so that a limited number of (IHC) stains, are used to determine site of origin.

D. Request pathologists proceed with molecular analysis only after histologic confirmation of malignancy.

E. All of the above
incorrect correct
Each fictitious clinical case scenario is based on a conglomerate of real patient data. Cases have been modified to avoid any possibility for patient identification and to help meet educational objectives. Any resemblance to real persons, living or deceased, is purely coincidental.

The content for these webcasts has been developed by members of the World Association for Bronchology and Interventional Pulmonology. All content was reviewed by an independent multidisciplinary team of experts. Unless otherwise specified, all content is the property of WABIP.
A collaborative project with Pfizer Oncology